K-pop

JYP Responds to Rumors of Tzuyu’s Contract Not Being Renewed: “Discussions Are Underway… We Will Announce Once It’s Finalized”

Discussions Underway on Contract Renewals for All Members Following reports on Jeong Yeon, news about Tzuyu has emerged

KIM HYUNSIK
2026-07-14 13:42:51
[Edaily Starin KIM HYUNSIK Reporter] Rumors have surfaced that TWICE member Tzuyu (Na-yeon, Jeong-yeon, Momo, Sana, Jihyo, Mina, Dahyun, Chaeyoung, Tzuyu) has failed to renew her contract with JYP Entertainment (JYP).
TWICE’s Tzuyu (Photo = E-Daily DB)
On the 14th, News1 reported that Tzuyu had agreed not to renew her contract with JYP and to continue participating only in activities with TWICE as a full group.
In response, a JYP representative told Edaily that day that discussions regarding contract renewals with the TWICE members are still ongoing, adding, “We will make an announcement as soon as the matter is finalized.”
Since their debut in October 2015, TWICE has promoted with songs such as “CHEER UP,” “TT,” “KNOCK KNOCK,” “FANCY,” and “Feel Special.” They previously renewed their contract with JYP once in July 2022.
Amid this, it was reported on the 24th of last month that member Jeongyeon had a meeting to discuss a contract with an agency specializing in actors. In response, JYP stated that TWICE is currently in discussions for their second contract renewal and that they are “continuing to have careful discussions with the members.”

Economy

Corporation

IT·Science

Economy

Samsung DX Union Holds Long-Term Protest in Front of Jay Y. Lee’s Residence… “Close the Compensation Gap”

“Donghaeng,” a labor union composed primarily of employees from SamsungElectronics’ Device Experience (DX) Division, is holding a rally in front of Jay Y. Lee’s residence to demand the elimination of …
2026-09-05 14:21:39

Corporation

SK BIOPHARMACEUTICALS’s $400 Million Gamble… A Bigger Picture Than ‘A Second Excofry’ [Invest Bio]

SK BIOPHARMACEUTICALS(326030)is attributing significance beyond that of a mere follow-up pipeline to Opakalim (BHV-7000), a new epilepsy drug candidate it acquired from the U.S.-based Biohaven. It is …
2026-09-05 06:01:02

IT·Science

GC Wellbeing and JW Pharmaceutical Rally [K-bio Pulse]

South Korea’s pharmaceutical and biotech sector experienced significant volatility on August 13, driven by growth themes in obesity/medical aesthetics, hair loss, and immuno-oncology. #GCWellbeing sur…
2026-09-05 08:02:02